Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma ; volume:21 ; number:1 ; day:19 ; month:4 ; year:2021 ; pages:1-12 ; date:12.2021
Cancer cell international ; 21, Heft 1 (19.4.2021), 1-12, 12.2021
- Creator
-
Jou, Yeong-Chin
Lin, Guan-Ling
Lin, Hon-Yi
Huang, Wan-Hong
Chuang, Yu-Ming
Lin, Ru-Inn
Chen, Pie-Che
Wu, Shu-Fen
Shen, Cheng-Huang
Chan, Michael W. Y.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-021-01925-9
- URN
-
urn:nbn:de:101:1-2021060612545642964096
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jou, Yeong-Chin
- Lin, Guan-Ling
- Lin, Hon-Yi
- Huang, Wan-Hong
- Chuang, Yu-Ming
- Lin, Ru-Inn
- Chen, Pie-Che
- Wu, Shu-Fen
- Shen, Cheng-Huang
- Chan, Michael W. Y.
- SpringerLink (Online service)
Other Objects (12)
Combined epigenetic/genetic study identified an ALS age of onset modifier
The epigenetic modifier Fam208a is required to maintain epiblast cell fitness
Lineage-specific regulation of epigenetic modifier genes in human liver and brain
Oocyte TET3: an epigenetic modifier responsible for maternal inheritance of glucose intolerance
Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma
Targeting the epigenetic modifier HDAC6 for cancer therapy and for overcoming drug resistance
Author Correction: The epigenetic modifier Fam208a is required to maintain epiblast cell fitness
The fusiform gyrus exhibits an epigenetic signature for Alzheimer’s disease
Epigenetic engineering and the art of epigenetic manipulation
Epigenetic modifier alpha-ketoglutarate modulates aberrant gene body methylation and hydroxymethylation marks in diabetic heart
Epigenetic drug discovery
Obesity: epigenetic aspects
Combined epigenetic/genetic study identified an ALS age of onset modifier
The epigenetic modifier Fam208a is required to maintain epiblast cell fitness
Lineage-specific regulation of epigenetic modifier genes in human liver and brain
Oocyte TET3: an epigenetic modifier responsible for maternal inheritance of glucose intolerance
Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma
Targeting the epigenetic modifier HDAC6 for cancer therapy and for overcoming drug resistance
Author Correction: The epigenetic modifier Fam208a is required to maintain epiblast cell fitness
The fusiform gyrus exhibits an epigenetic signature for Alzheimer’s disease
Epigenetic engineering and the art of epigenetic manipulation
Epigenetic modifier alpha-ketoglutarate modulates aberrant gene body methylation and hydroxymethylation marks in diabetic heart
Epigenetic drug discovery
Obesity: epigenetic aspects
Combined epigenetic/genetic study identified an ALS age of onset modifier
The epigenetic modifier Fam208a is required to maintain epiblast cell fitness
Lineage-specific regulation of epigenetic modifier genes in human liver and brain
Oocyte TET3: an epigenetic modifier responsible for maternal inheritance of glucose intolerance
Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma
Targeting the epigenetic modifier HDAC6 for cancer therapy and for overcoming drug resistance
Author Correction: The epigenetic modifier Fam208a is required to maintain epiblast cell fitness
The fusiform gyrus exhibits an epigenetic signature for Alzheimer’s disease
Epigenetic engineering and the art of epigenetic manipulation
Epigenetic modifier alpha-ketoglutarate modulates aberrant gene body methylation and hydroxymethylation marks in diabetic heart
Epigenetic drug discovery